Hassan Alshaker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hassan Alshaker has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Ahmad Nawlo
Faculty of Medicine, University of Aleppo, Aleppo, Syria
1 shared publication - Alexis Liakos
Brigham and Women’s Hospital, Boston, MA 02115, USA
1 shared publication - Andres Franceschi Coll
Brigham and Women’s Hospital, Boston, MA 02115, USA
1 shared publication - Anwar Chammout
University of Aleppo, Faculty of Medicine, Aleppo, Syria; Department of Pathology, University of Aleppo, Faculty of Medicine, Aleppo, Syria
1 shared publication - Christine J. Atallah
Brigham and Women’s Hospital, Boston, MA 02115, USA
1 shared publication - Dimitrios G. Moshovitis
Brigham and Women’s Hospital, Boston, MA 02115, USA
1 shared publication
Latest Publications
- Open Access
- 19 October 2024
- Published by MDPI AG in Journal of Fungi
- Vol. 10 (10) , 727
Recent Advances in Diagnostic Approaches for Mucormycosis
Mucormycosis, an invasive fungal infection caused by members of the order Mucorales, often progresses fulminantly if not recognized in a timely manner. This comprehensive review discusses the latest developments in diagnostic approaches for mucormycosis, from traditional histopathology and culture-based methods to advanced and emerging techniques such as molecular assays, imaging, serology, and metabolomics. We discuss challenges in the diagnosis of mucormycosis and emphasize the importance of rapid and accurate identification of this life-threatening infection.
- 19 October 2024
- Published by MDPI AG in Journal of Fungi
- Vol. 10 (10) , 727
Open AccessRecent Advances in Diagnostic Approaches for Mucormycosis
Mucormycosis, an invasive fungal infection caused by members of the order Mucorales, often progresses fulminantly if not recognized in a timely manner. This comprehensive review discusses the latest developments in diagnostic approaches for mucormycosis, from traditional histopathology and culture-based methods to advanced and emerging techniques such as molecular assays, imaging, serology, and metabolomics. We discuss challenges in the diagnosis of mucormycosis and emphasize the importance of rapid and accurate identification of this life-threatening infection.
- Open Access
- 17 October 2023
- Published by Wiley in Clinical Case Reports
- Vol. 11 (10) , e8068
Metastatic signet‐ring cell carcinoma of the testis: An unusual case report in Syria
Key Clinical Message: The case of a 44‐year‐old male with signet‐ring cell adenocarcinoma metastasis in the testis emphasizes the significance of immunohistochemistry in identifying the primary site of metastatic tumors. Further research is needed to establish effective treatment strategies for rare malignancies like small intestine signet‐ring cell carcinoma. Early diagnosis and appropriate treatment are crucial for improved patient outcomes. Metastasis to the testes is a rare occurrence, and identifying the primary site of origin can pose a significant challenge. Signet‐ring cell carcinoma (SRCC) is an uncommon subtype of adenocarcinoma typically found in the stomach but can also occur in other organs. This case report presents a 44‐year‐old male with signet‐ring cell adenocarcinoma metastasis in the right testis. The patient's initial clinical manifestation was testicular painful swelling, and subsequent immunohistochemical analysis using CK7, CK20, and CDX2 markers suggested a gastrointestinal origin. Normal upper and lower endoscopies rise suspicion of a small intestinal origin. The rarity of SRCC of the small intestine and the lack of clinical trials make treatment decisions difficult. This case highlights the importance of immunohistochemistry in determining the primary site of metastatic tumors and underscores the need for further research to establish optimal treatment strategies for rare malignancies like SRCC of the small intestine. As early diagnosis and appropriate treatment are critical for better patient outcomes.
- 17 October 2023
- Published by Wiley in Clinical Case Reports
- Vol. 11 (10) , e8068
Open AccessMetastatic signet‐ring cell carcinoma of the testis: An unusual case report in Syria
Key Clinical Message: The case of a 44‐year‐old male with signet‐ring cell adenocarcinoma metastasis in the testis emphasizes the significance of immunohistochemistry in identifying the primary site of metastatic tumors. Further research is needed to establish effective treatment strategies for rare malignancies like small intestine signet‐ring cell carcinoma. Early diagnosis and appropriate treatment are crucial for improved patient outcomes. Metastasis to the testes is a rare occurrence, and identifying the primary site of origin can pose a significant challenge. Signet‐ring cell carcinoma (SRCC) is an uncommon subtype of adenocarcinoma typically found in the stomach but can also occur in other organs. This case report presents a 44‐year‐old male with signet‐ring cell adenocarcinoma metastasis in the right testis. The patient's initial clinical manifestation was testicular painful swelling, and subsequent immunohistochemical analysis using CK7, CK20, and CDX2 markers suggested a gastrointestinal origin. Normal upper and lower endoscopies rise suspicion of a small intestinal origin. The rarity of SRCC of the small intestine and the lack of clinical trials make treatment decisions difficult. This case highlights the importance of immunohistochemistry in determining the primary site of metastatic tumors and underscores the need for further research to establish optimal treatment strategies for rare malignancies like SRCC of the small intestine. As early diagnosis and appropriate treatment are critical for better patient outcomes.